PregnancyNCT07906743
Mandala Coloring in Late Pregnancy
A study testing Mandala Coloring Group in people with Pregnancy and Anxiety, run by Fidan Balkaya at 1 site in Turkey (Türkiye).
Trial summary
Anxiety, depression and poor sleep are common in the last months of pregnancy and often occur together. Medication options during pregnancy are limited, so simple, safe non-drug methods are needed. Read more about this study
- Who is it for?
- Ages 18 years and older, women onlyHealthy volunteers can take part
- Conditions the study is for
- Pregnancy, Anxiety, Depression
- What is being tested?
- Mandala Coloring Group
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 186 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 10 Nov 2026to 28 Feb 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- Women only
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- • Presenting to the Obstetrics and Gynecology Outpatient Clinics of Malatya Training and Research Hospital
- Being in the 28th week of gestation
- Being 18 years of age or older
- Having a singleton, low-risk (healthy) pregnancy
- Being able to understand and speak Turkish and being literate
- Agreeing to participate in the study voluntarily
- Having no physical limitation preventing mandala coloring (being able to use hand and arm movements)
Who cannot join
- Having a diagnosed psychiatric disorder or currently using psychotropic medication
- Having a diagnosed sleep disorder or currently using sleep medication
- Having a visual or cognitive impairment that prevents mandala coloring or completing the questionnaires
- Currently participating in another psychological, art-based or mind-body program (e.g., art therapy, yoga, meditation, mindfulness)
- Having a diagnosed pregnancy complication (e.g., preeclampsia, gestational diabetes, placenta previa, threatened preterm labor) at enrollment
- Withdrawal Criteria:
Show all 10Show fewer
- Developing a pregnancy complication requiring hospitalization or giving birth before the posttest assessment
- Using any pharmacological or non-pharmacological method for anxiety, depression or sleep problems during the study
- Not completing at least 75% of the coloring sessions (12 of 16) in the intervention group
- Withdrawing consent at any time
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Turkey (Türkiye)1 site
Inonu University Faculty of Nursing
Malatya, Battalgazi, 44280
About this study
Official title: Effects of Mandala Art Therapy in Late Pregnancy on Expectant Mothers' Mental Health and Sleep: A Randomized Controlled Trial
Anxiety, depression and poor sleep are common in the last months of pregnancy and often occur together. Medication options during pregnancy are limited, so simple, safe non-drug methods are needed. Mandala coloring is an art therapy technique in which a person colors circular patterns; it helps focus attention on the present moment and may have a calming effect.
This randomized controlled trial will examine whether mandala coloring during the third trimester reduces depression, anxiety and stress, improves sleep, and reduces fear of childbirth. It will also look at birth outcomes and the childbirth experience. Pregnant women at 28 weeks of gestation who attend the obstetrics outpatient clinics of Malatya Training and Research Hospital will be randomly assigned to a mandala coloring group or a control group. Women in the mandala group will color two mandalas a week at home for 8 weeks (16 mandalas in total, about 20-30 minutes per session). Women in the control group will receive routine antenatal care only and will be offered the mandala materials after the study ends.
Read the detailed description
Background Pregnancy involves physiological, psychological, hormonal and social changes. Pregnancy-related anxiety affects about 15-23% of pregnant women, and the prevalence of antenatal depression ranges from 15% to 65%, becoming more marked in the third trimester. Poor sleep quality affects 29-76% of pregnant women and reaches about 60% in the third trimester. Sleep problems, anxiety and depression are closely linked and reinforce one another. These problems are associated with adverse maternal and neonatal outcomes, including postpartum mental health problems, low birth weight, preterm birth, preeclampsia, gestational diabetes and cesarean delivery. Because pharmacological treatment is used cautiously in pregnancy, non-pharmacological approaches are important. Mandala coloring has reduced anxiety and depressive symptoms in various populations and has reduced anxiety and fear of childbirth in pregnant women. However, most studies have examined a single outcome over a short follow-up period, and few have assessed anxiety, depression and sleep together while following women until birth.
Objective To evaluate the effect of mandala coloring in the third trimester on depression, anxiety, stress, insomnia, fear of childbirth, childbirth experience and birth outcomes.
Design Two-arm, parallel-group, randomized controlled trial.
Setting and period Obstetrics and Gynecology Outpatient Clinics of Malatya Training and Research Hospital, Malatya, Türkiye; November 2027 - February 2028.
Participants Pregnant women aged 18 years or older at 28 weeks of gestation with a singleton, low-risk pregnancy who can understand, speak, read and write Turkish, have no physical limitation that prevents coloring, and agree to participate voluntarily.
Randomization and allocation concealment Participants will be randomized 1:1 to the intervention or control group using a computer-generated block randomization list with a block size of 4. The list will be prepared by a researcher independent of the study, and allocation will be concealed using sequentially numbered, opaque, sealed envelopes.
Intervention group Participants will receive a standard verbal and written briefing on the purpose, duration, session frequency and materials of the intervention. Each participant will receive a set of 7-color felt-tip pens and 16 ready-made mandala templates of her choice. She will color two mandalas a week for 8 weeks (16 sessions in total, about 20-30 minutes each) at home, at a time convenient for her, in a calm and quiet setting. To monitor adherence, participants will send a message to the researcher before each session and a photograph of the completed mandala afterwards. Regular reminder messages will be sent throughout the intervention.
Control group Participants will continue their routine antenatal care and will receive no intervention. Participants found to use any pharmacological or non-pharmacological method for the study outcomes during the study period will be excluded. After the study is completed, mandala coloring information and materials will be offered to the control group.
Outcome measures and time points
- Pretest (28 weeks of gestation, before the intervention): Personal Information Form, Depression Anxiety Stress Scale-21 (DASS-21), Women's Health Initiative Insomnia Rating Scale (WHIIRS) and Wijma Delivery Expectancy/Experience Questionnaire Version A (W-DEQ A).
- Posttest (after the 8-week intervention, before birth): DASS-21, WHIIRS and W-DEQ A.
- Postpartum: Wijma Delivery Expectancy/Experience Questionnaire Version B (W-DEQ B) and the Postpartum Parameters Form (mode of delivery, duration of labor, birth weight, 1- and 5-minute Apgar scores, gestational age at birth, and maternal/neonatal complications), recorded from patient files and delivery records.
Data will be collected by the researcher through face-to-face interviews.
Sample size G*Power 3.1 power analysis (one-tailed, α = 0.05, power = 0.95, effect size d = 0.50) indicated 88 participants per group. Allowing for 5% attrition, 93 participants per group (186 in total) will be recruited.
Statistical analysis Data will be analyzed with SPSS 22.0. Descriptive statistics (number, percentage, mean, standard deviation), the chi-square test, the independent samples t-test, the paired samples t-test or repeated measures analysis of variance, and Cronbach's alpha will be used.
- Conditions
- Pregnancy, Anxiety, Depression, Psychological Stress, Sleep Initiation and Maintenance Disorders, Fear of Childbirth
- Being tested
- Mandala Coloring Group
- Keywords
- Mandala coloring, Art therapy, Third trimester, Prenatal anxiety, Antenatal depression, Sleep quality, Childbirth experience, Non-pharmacological intervention
- Medical subject headings
- Anxiety Disorders, Depression, Stress, Psychological, Sleep Initiation and Maintenance Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Mandala Coloring GroupBehavioural
Participants color two ready-made mandala templates per week for 8 weeks (16 sessions in total, approximately 20-30 minutes each) at home, at a time convenient for them, in a calm and quiet setting. Each participant receives a set of 7-color felt-tip pens and 16 mandala templates of her choice, together with a standard verbal and written briefing on the purpose, duration, session frequency and materials of the intervention. Adherence is monitored through a message sent to the researcher before each session and a photograph of the completed mandala sent afterwards; regular reminder messages are sent throughout the intervention.
| Study group | Role | What they receive |
|---|---|---|
| Mandala Coloring Group | Experimental | Before the study begins, participants in the experimental group will receive a standard briefing on the mandala coloring intervention from the researcher. In this briefing, participants will be given verbal and written information on the purpose and duration of the intervention, the frequency of sessions and the materials to be used. The intervention will be continued for a total of 8 weeks, with 2 sessions per week. During this period, participants will color 2 mandalas each week, 16 mandalas in total. Each session is planned to last approximately 20-30 minutes. Receives: Behavioral: Mandala Coloring Group |
| Control Group | No intervention | Participants continue their routine antenatal care and receive no intervention during the study. After the study is completed, mandala coloring information and materials will be offered to this group. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in Depression Score (DASS-21 Depression Subscale)
Depression will be assessed with the depression subscale of the Depression Anxiety Stress Scale-21 (DASS-21). The subscale consists of 7 items rated on a 4-point Likert scale (0-3); the subscale score is multiplied by two, giving a range of 0 to 42. Higher scores indicate more severe depression.
Measured: aseline (28 weeks of gestation) and after the 8-week intervention (36 weeks of gestation)
Secondary outcomes (1)
Change in Anxiety Score (DASS-21 Anxiety Subscale)
Anxiety will be assessed with the anxiety subscale of the Depression Anxiety Stress Scale-21 (DASS-21). The subscale consists of 7 items rated on a 4-point Likert scale (0-3); the subscale score is multiplied by two, giving a range of 0 to 42. Higher scores indicate more severe anxiety.
Measured: Baseline (28 weeks of gestation) and after the 8-week intervention (36 weeks of gestation)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted30 Oct 2026
- Study start10 Nov 2026 (estimated)
- Primary completion5 Jan 2027 (estimated)
- Study completion28 Feb 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for PregnancyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- The study will be conducted using a two-arm, parallel-group randomized controlled design with an experimental group and a control group.
- Masking
- None (open label)
- Enrolment
- 186 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Fidan Balkaya
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor-investigator, Fidan Balkaya, Inonu University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07906743
- Sponsor's protocol ID
- Inonu Faculty of Nursing
- Status last verified
- Oct 2026
- First submitted
- 26 Oct 2026
- Last updated
- 30 Oct 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Individual participant data will not be shared. Participants were not asked to consent to the sharing of their data with third parties, and the ethics committee approval covers the use of the data by the research team only. To protect the confidentiality of participants, who are pregnant women recruited from a single hospital, the data will be stored securely by the research team and used only for the purposes of this study. Aggregate results will be reported in peer-reviewed publications.
Study at a glance
From the registry record, last updated by the sponsor on 30 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effects of Mandala Art Therapy in Late Pregnancy on Expectant Mothers' Mental Health and Sleep: A Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT07906743
- Acronym / sponsor ID
- Inonu Faculty of Nursing
- Conditions
- Pregnancy, Anxiety, Depression, Psychological Stress, Sleep Initiation and Maintenance Disorders, Fear of Childbirth
- Keywords
- Mandala coloring, Art therapy, Third trimester, Prenatal anxiety, Antenatal depression, Sleep quality, Childbirth experience, Non-pharmacological intervention
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 186 participants (estimated)
- Lead sponsor
- Fidan BalkayaUniversity, hospital or other
- Study start
- 10 Nov 2026 (estimated)
- Primary completion
- 5 Jan 2027 (estimated)
- Study completion
- 28 Feb 2027 (estimated)
- First posted
- 30 Oct 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Anxiety, depression and poor sleep are common in the last months of pregnancy and often occur together. Medication options during pregnancy are limited, so simple, safe non-drug methods are needed. Mandala coloring is an art therapy technique in which a person colors circular patterns; it helps focus attention on the present moment and may have a calming effect.
This randomized controlled trial will examine whether mandala coloring during the third trimester reduces depression, anxiety and stress, improves sleep, and reduces fear of childbirth. It will also look at birth outcomes and the childbirth experience. Pregnant women at 28 weeks of gestation who attend the obstetrics outpatient clinics of Malatya Training and Research Hospital will be randomly assigned to a mandala coloring group or a control group. Women in the mandala group will color two mandalas a week at home for 8 weeks (16 mandalas in total, about 20-30 minutes per session). Women in the control group will receive routine antenatal care only and will be offered the mandala materials after the study ends.
Detailed description
Background Pregnancy involves physiological, psychological, hormonal and social changes. Pregnancy-related anxiety affects about 15-23% of pregnant women, and the prevalence of antenatal depression ranges from 15% to 65%, becoming more marked in the third trimester. Poor sleep quality affects 29-76% of pregnant women and reaches about 60% in the third trimester. Sleep problems, anxiety and depression are closely linked and reinforce one another. These problems are associated with adverse maternal and neonatal outcomes, including postpartum mental health problems, low birth weight, preterm birth, preeclampsia, gestational diabetes and cesarean delivery. Because pharmacological treatment is used cautiously in pregnancy, non-pharmacological approaches are important. Mandala coloring has reduced anxiety and depressive symptoms in various populations and has reduced anxiety and fear of childbirth in pregnant women. However, most studies have examined a single outcome over a short follow-up period, and few have assessed anxiety, depression and sleep together while following women until birth.
Objective To evaluate the effect of mandala coloring in the third trimester on depression, anxiety, stress, insomnia, fear of childbirth, childbirth experience and birth outcomes.
Design Two-arm, parallel-group, randomized controlled trial.
Setting and period Obstetrics and Gynecology Outpatient Clinics of Malatya Training and Research Hospital, Malatya, Türkiye; November 2027 - February 2028.
Participants Pregnant women aged 18 years or older at 28 weeks of gestation with a singleton, low-risk pregnancy who can understand, speak, read and write Turkish, have no physical limitation that prevents coloring, and agree to participate voluntarily.
Randomization and allocation concealment Participants will be randomized 1:1 to the intervention or control group using a computer-generated block randomization list with a block size of 4. The list will be prepared by a researcher independent of the study, and allocation will be concealed using sequentially numbered, opaque, sealed envelopes.
Intervention group Participants will receive a standard verbal and written briefing on the purpose, duration, session frequency and materials of the intervention. Each participant will receive a set of 7-color felt-tip pens and 16 ready-made mandala templates of her choice. She will color two mandalas a week for 8 weeks (16 sessions in total, about 20-30 minutes each) at home, at a time convenient for her, in a calm and quiet setting. To monitor adherence, participants will send a message to the researcher before each session and a photograph of the completed mandala afterwards. Regular reminder messages will be sent throughout the intervention.
Control group Participants will continue their routine antenatal care and will receive no intervention. Participants found to use any pharmacological or non-pharmacological method for the study outcomes during the study period will be excluded. After the study is completed, mandala coloring information and materials will be offered to the control group.
Outcome measures and time points
- Pretest (28 weeks of gestation, before the intervention): Personal Information Form, Depression Anxiety Stress Scale-21 (DASS-21), Women's Health Initiative Insomnia Rating Scale (WHIIRS) and Wijma Delivery Expectancy/Experience Questionnaire Version A (W-DEQ A).
- Posttest (after the 8-week intervention, before birth): DASS-21, WHIIRS and W-DEQ A.
- Postpartum: Wijma Delivery Expectancy/Experience Questionnaire Version B (W-DEQ B) and the Postpartum Parameters Form (mode of delivery, duration of labor, birth weight, 1- and 5-minute Apgar scores, gestational age at birth, and maternal/neonatal complications), recorded from patient files and delivery records.
Data will be collected by the researcher through face-to-face interviews.
Sample size G*Power 3.1 power analysis (one-tailed, α = 0.05, power = 0.95, effect size d = 0.50) indicated 88 participants per group. Allowing for 5% attrition, 93 participants per group (186 in total) will be recruited.
Statistical analysis Data will be analyzed with SPSS 22.0. Descriptive statistics (number, percentage, mean, standard deviation), the chi-square test, the independent samples t-test, the paired samples t-test or repeated measures analysis of variance, and Cronbach's alpha will be used.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- The study will be conducted using a two-arm, parallel-group randomized controlled design with an experimental group and a control group.
| Arm | Type | Receives |
|---|---|---|
| Mandala Coloring Group | Experimental | Behavioral: Mandala Coloring GroupBefore the study begins, participants in the experimental group will receive a standard briefing on the mandala coloring intervention from the researcher. In this briefing, participants will be given verbal and written information on the purpose and duration of the intervention, the frequency of sessions and the materials to be used. The intervention will be continued for a total of 8 weeks, with 2 sessions per week. During this period, participants will color 2 mandalas each week, 16 mandalas in total. Each session is planned to last approximately 20-30 minutes. |
| Control Group | No intervention | –Participants continue their routine antenatal care and receive no intervention during the study. After the study is completed, mandala coloring information and materials will be offered to this group. |
Who may qualify
- Ages
- 18 years and older
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (7 listed)
- • Presenting to the Obstetrics and Gynecology Outpatient Clinics of Malatya Training and Research Hospital
Key exclusion criteria (10 listed)
- Having a diagnosed psychiatric disorder or currently using psychotropic medication
- Having a diagnosed sleep disorder or currently using sleep medication
- Having a visual or cognitive impairment that prevents mandala coloring or completing the questionnaires
- Currently participating in another psychological, art-based or mind-body program (e.g., art therapy, yoga, meditation, mindfulness)
- Having a diagnosed pregnancy complication (e.g., preeclampsia, gestational diabetes, placenta previa, threatened preterm labor) at enrollment
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Mandala Coloring GroupParticipants color two ready-made mandala templates per week for 8 weeks (16 sessions in total, approximately 20-30 minutes each) at home, at a time convenient for them, in a calm and quiet setting. Each participant receives a set of 7-color felt-tip pens and 16 mandala templates of her choice, together with a standard verbal and written briefing on the purpose, duration, session frequency and materials of the intervention. Adherence is monitored through a message sent to the researcher before each session and a photograph of the completed mandala sent afterwards; regular reminder messages are sent throughout the intervention. | Behavioural | Mandala Coloring Group |
Primary outcome
Change in Depression Score (DASS-21 Depression Subscale)
Time frame: aseline (28 weeks of gestation) and after the 8-week intervention (36 weeks of gestation)
Depression will be assessed with the depression subscale of the Depression Anxiety Stress Scale-21 (DASS-21). The subscale consists of 7 items rated on a 4-point Likert scale (0-3); the subscale score is multiplied by two, giving a range of 0 to 42. Higher scores indicate more severe depression.
1 secondary outcome
Change in Anxiety Score (DASS-21 Anxiety Subscale)
Time frame: Baseline (28 weeks of gestation) and after the 8-week intervention (36 weeks of gestation)
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 30 Oct 2026.
- Individual participant dataSharing planned: No. Individual participant data will not be shared. Participants were not asked to consent to the sharing of their data with third parties, and the ethics committee approval covers the use of the data by the research team only. To protect the confidentiality of participants, who are pregnant women recruited from a single hospital, the data will be stored securely by the research team and used only for the purposes of this study. Aggregate results will be reported in peer-reviewed publications.
Related trials for Pregnancy
Active, not recruitingPhase 1/2
A Beta-only IL-2 ImmunoTherapY Study
Advanced Solid Tumor, Unresectable Solid Tumor
Active, not recruitingPhase 2
Treating Muscle-invasive Bladder Cancer With A Non-surgical Method Consisting of Anti-PD-1 Therapy and Chemoradiation
Muscle-Invasive Bladder Carcinoma, Programmed Cell Death Protein 1 Inhibitor
Not yet recruiting
Ultrasound-Guided Radiofrequency Ablation for Focal Adenomyosis
Adenomyosis, Adenomyoma of Uterus
RecruitingPhase 2
Neurovascular Regulation During Exercise in Humans With Chronic Kidney Disease: Sympatholysis in CKD
Chronic Kidney Disease
Not yet recruiting
Combined Versus Multicomponent Training in People With Chronic Kidney Disease Stages 3a and 3b
Chronic Kidney Disease Stage 3A, Chronic Kidney Disease Stage 3B
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Mandala Coloring Group in people with Pregnancy and Anxiety, run by Fidan Balkaya at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 30 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Fidan Balkaya, PhD (+90 422 377 30 00 ext. 0000, fidan.balkaya@inonu.edu.tr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in Depression Score (DASS-21 Depression Subscale) (time frame: aseline (28 weeks of gestation) and after the 8-week intervention (36 weeks of gestation)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Oct 2026.